Learn more about whether Catalyst Pharmaceuticals, Inc. or Ionis Pharmaceuticals, Inc. is a better investment based on AAII's ...
Baird initiated coverage on Catalyst Pharmaceutical Partners (NASDAQ:CPRX) with an Outperform rating and set a price target ...
Baird analyst Joel Beatty last night initiated coverage of Catalyst Pharmaceuticals (CPRX) with an Outperform rating and $28 price target ...
DAVENPORT & Co LLC reduced its position in shares of argenx SE (NASDAQ:ARGX – Free Report) by 5.1% during the fourth quarter, ...
3 天
Fintel on MSNBaird Initiates Coverage of Catalyst Pharmaceuticals (CPRX) with Outperform RecommendationFintel reports that on February 4, 2025, Baird initiated coverage of Catalyst Pharmaceuticals (NasdaqCM:CPRX) with a ...
The healthcare industry is set for growth due to advancements in targeted treatments and personalized care and the rapid ...
The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors ...
Social cognition is a complex process that requires the integration of a wide variety of behaviors, including salience, reward-seeking, motivation, knowledge of self and others, and flexibly adjusting ...
Pacer Advisors Inc. decreased its position in argenx SE (NASDAQ:ARGX – Free Report) by 5.2% during the fourth quarter, Holdings Channel reports. The fund owned 789 shares of the company’s stock after ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果